Demo Pharmaceutical Industry

DEMO Pharmaceuticals is a established, commercial-stage Greek pharmaceutical manufacturer with a significant global export footprint. Its core strength lies in large-scale production, particularly of injectables, from its state-of-the-art facilities in Kryoneri, Attica. With over 3,300 approved products, a workforce exceeding 1,700, and status as a supplier to major international organizations like the UN and WHO, DEMO is a key player in improving access to quality medicines in both developed and emerging markets. The company's strategy combines portfolio expansion, continuous investment in R&D and production capacity, and a mission-driven focus on healthcare accessibility.

Integrated Pharmaceutical Development & Manufacturing, with a core strength in large-scale, advanced manufacturing of sterile injectables and a focused R&D program on controlled-release injectable formulations.

DEMO competes in the global generic pharmaceutical and injectables manufacturing space against other large international generics companies (e.g., Teva, Sandoz, Viatris) and regional players. Its competitive advantages are its massive, state-of-the-art injectables production capacity in Europe, its broad portfolio of over 3,300 approved products, and its established, trusted relationships with major humanitarian procurement agencies.